@article{a8ee4b7537cd4b40b25c6ea4636c7eab,
title = "Capturing the Onset of PRC2-Mediated Repressive Domain Formation",
abstract = "Polycomb repressive complex 2 (PRC2) maintains gene silencing by catalyzing methylation of histone H3 at lysine 27 (H3K27me2/3) within chromatin. By designing a system whereby PRC2-mediated repressive domains were collapsed and then reconstructed in an inducible fashion in vivo, a two-step mechanism of H3K27me2/3 domain formation became evident. First, PRC2 is stably recruited by the actions of JARID2 and MTF2 to a limited number of spatially interacting “nucleation sites,” creating H3K27me3-forming Polycomb foci within the nucleus. Second, PRC2 is allosterically activated via its binding to H3K27me3 and rapidly spreads H3K27me2/3 both in cis and in far-cis via long-range contacts. As PRC2 proceeds further from the nucleation sites, its stability on chromatin decreases such that domains of H3K27me3 remain proximal, and those of H3K27me2 distal, to the nucleation sites. This study demonstrates the principles of de novo establishment of PRC2-mediated repressive domains across the genome. Oksuz et al. define nucleation and spreading regions for Polycomb repressive complex 2 (PRC2), demonstrating the principle of PRC2 domain formation in mammals. They elucidate the role of genome architecture in formation of these domains and identify JARID2 and MTF2 as being crucial for full recruitment of PRC2 to chromatin.",
keywords = "H3K27me2/3 domains, JARID2, MTF2, Polycomb, epigenetics, nucleation, spreading",
author = "Ozgur Oksuz and Varun Narendra and Lee, {Chul Hwan} and Nicolas Descostes and Gary LeRoy and Ramya Raviram and Lili Blumenberg and Kelly Karch and Rocha, {Pedro P.} and Garcia, {Benjamin A.} and Skok, {Jane A.} and Danny Reinberg",
note = "Funding Information: We thank Drs. L. Vales, K.J. Armache, and E.O. Mazzoni for comments on the manuscript; J. Granat for technical assistance; Drs. R.A. Ganai, T. Escobar, and S. Krishnan for discussions; Y. Grobler for providing Drosophila S2R+ cells; Drs. A. Sfeir and R.J. Klose for kind gifts of the C57BL/6 mESCs and KDM2B antibody, respectively; New York University Langone Medical Center (NYULMC) Genome Technology Center, particularly A. Heguy, P. Zappile, and P. Meyn, for help with sequencing; NYULMC Cytometry and Cell Sorting Core for help with FACS; and NYULMC Microscopy Core for help with imaging. The NYULMC Genome Technology Center and the NYUMC Cytometry and Cell Sorting Core are partially supported by the Cancer Center Support Grant, P30CA016087, at the Laura and Isaac Perlmutter Cancer Center. This work utilized computing resources at the High-Performance Computing Facility of the Center for Health Informatics and Bioinformatics at the NYULMC. P.P.R. is a National Cancer Center and American Society of Hematology Fellow and has a K99 Career Transition Award (K99GM117302). This work was supported by grants from the National Cancer Institute (9R01CA199652-13A1 to D.R.), the Howard Hughes Medical Institute (to D.R.), and the NIH (R01GM086852 and R01GM112192 to J.A.S.; GM110174 and CA196539 to B.A.G.). Funding Information: We thank Drs. L. Vales, K.J. Armache, and E.O. Mazzoni for comments on the manuscript; J. Granat for technical assistance; Drs. R.A. Ganai, T. Escobar, and S. Krishnan for discussions; Y. Grobler for providing Drosophila S2R+ cells; Drs. A. Sfeir and R.J. Klose for kind gifts of the C57BL/6 mESCs and KDM2B antibody, respectively; New York University Langone Medical Center (NYULMC) Genome Technology Center, particularly A. Heguy, P. Zappile, and P. Meyn, for help with sequencing; NYULMC Cytometry and Cell Sorting Core for help with FACS; and NYULMC Microscopy Core for help with imaging. The NYULMC Genome Technology Center and the NYUMC Cytometry and Cell Sorting Core are partially supported by the Cancer Center Support Grant , P30CA016087 , at the Laura and Isaac Perlmutter Cancer Center. This work utilized computing resources at the High-Performance Computing Facility of the Center for Health Informatics and Bioinformatics at the NYULMC. P.P.R. is a National Cancer Center and American Society of Hematology Fellow and has a K99 Career Transition Award ( K99GM117302 ). This work was supported by grants from the National Cancer Institute ( 9R01CA199652-13A1 to D.R.), the Howard Hughes Medical Institute (to D.R.), and the NIH ( R01GM086852 and R01GM112192 to J.A.S.; GM110174 and CA196539 to B.A.G.). Publisher Copyright: {\textcopyright} 2018 Elsevier Inc.",
year = "2018",
month = jun,
day = "21",
doi = "10.1016/j.molcel.2018.05.023",
language = "English",
volume = "70",
pages = "1149--1162.e5",
journal = "Molecular cell",
issn = "1097-2765",
number = "6",
}